Dissertation/Thesis Abstract

Corporate social responsibility in pharmaceutical companies
by Korkmaz, Nihan, M.A., The American University of Paris (France), 2011, 51; 10305680
Abstract (Summary)

As one of the famous business writers Peter Drucker implied “Profit for a company is like oxygen for a person; if you don't have enough of it, you are out of the game. (Senge, 2008, p:326) In our world, most of the companies operate as if their purpose is breathing. Certainly, the purpose of a company is to maximize profit but also they can make both profit and contribution. (Senge, 2008) This is the point where we can start talking about CSR because it is the idea of businesses to be aware of how they can contribute to their social and economical environment.

In this paper, I will try to imply the definition and the importance of R&D in pharmaceutical business, concluding that R&D is CSR, but also by illustrating how closely R&D is linked to the profit that the company can obtain from its investments.

Indexing (document details)
Advisor: Majidi, Mehdi
Commitee:
School: The American University of Paris (France)
Department: Cross-Cultural and Sustainable Business Management
School Location: France
Source: MAI 56/02M(E), Masters Abstracts International
Source Type: DISSERTATION
Subjects: Management, Pharmaceutical sciences
Keywords: Corporate social responsibility, Pharmaceutical companies, Profit, Research and development
Publication Number: 10305680
ISBN: 978-1-369-49244-6
Copyright © 2019 ProQuest LLC. All rights reserved. Terms and Conditions Privacy Policy Cookie Policy
ProQuest